• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Take a Look at the Target-Based Approaches for Discovering Novel Oncology Drugs

Posted on: Thursday, 2 February 2006, 06:00 CST

Research and Markets (http://www.researchandmarkets.com/reports/c32154) has announced the addition of Target-Based Approaches for Discovering Novel Oncology Drugs to their offering.

Despite recent improvements in treatment, cancer remains a huge public health burden. Cytotoxic treatments play a critical role in modern cancer therapy. Unfortunately, traditional cytotoxic agents are associated with significant toxicity. In an effort to discover new oncology drugs with improved clinical benefits and fewer side effects, drug developers have committed substantial resources to identifying novel cancer targets and compounds that interact with those targets. These efforts have been facilitated by a plethora of technologies developed in recent years to generate and exploit genomic and proteomic information. In this Decision Resources report, novel cancer drug targets and the drugs under development directed at these targets are reviewed.

This report looks at the following key topics:

-- Human Epidermal Growth Factor Receptors

-- Bcr/abl Kinase

-- The Proteasome

-- Apoptosis Pathways

-- Cellular Proliferation and Survival

-- Histone Deacetylase

-- Angiogenesis Targets

-- Outlook for Target-Based Approaches

For more information visit http://www.researchandmarkets.com/reports/c32154

Source: Business Wire

More News in this Category